Text Size
Donate

Record Attendance for 2nd Annual Glaucoma 360

On January 31, 2013, Glaucoma Research Foundation's Annual Benefit and Gala "Catalyst for a Cure" launched the 2nd Annual Glaucoma 360, a series of three events uniting medicine, research, industry, and philanthropy with one mission — to find a cure for glaucoma.

More than 420 attended the benefit gala and dinner held at the historic Palace Hotel in San Francisco, chaired by Nobuko Saito Cleary and Gary Cleary, PharmD, PhD. Mona and Ed Zander hosted the Innovators Circle reception, which included major donors, platinum level sponsors, researchers, and other distinguished guests.

The highlight of the gala was the presentation of Glaucoma Research Foundation's highest honor, the Catalyst Award to Frank Stein and Paul S. May for their outstanding leadership and commitment to forwarding innovative glaucoma research.

howell_brunner_prize_290.jpg

Gareth Howell received the Shaffer Prize

Gareth Howell, PhD received The Shaffer Prize for Innovative Glaucoma Research for his study investigating the mechanism by which a spontaneous mutation (Wallerian degeneration slow, Wlds) prevents retinal ganglion cell death in glaucoma.

Thomas Brunner, Glaucoma Research Foundation President and CEO, presented awards to Melza and F.T. Barr and Catalyst for a Cure principal investigators David Calkins, PhD, Philip Horner, PhD, Nicholas Marsh-Armstrong, PhD, and Monica Vetter, PhD, in recognition of their dedicated efforts to advance glaucoma research.

The evening concluded with a musical salute to Frank and Paul with a performance by a cast member from Steve Silver's Beach Blanket Babylon. See photos from the 2013 Benefit Gala.

graves_iwach_benefit_290.jpg

Drs. Adrienne Graves and Andrew Iwach

The following day, the 2nd Annual New Horizons Forum, co-founded by Adrienne Graves, PhD and Andrew Iwach, MD, brought together more than 250 highly respected leaders in medicine, science, business, venture capital, and the regulatory industry to share the latest advances in glaucoma therapies and research. This meeting provides the ultimate opportunity for collaboration and networking needed to advance novel concepts toward becoming new treatments for glaucoma patients.

Glaucoma 360 concluded on Saturday, February 2nd with more than 300 ophthalmologists attending the 17th Annual Glaucoma Symposium CME to learn about the latest and best practices in glaucoma management, medication, and surgical techniques.

Glaucoma Research Foundation is grateful for the generous support and dedicated involvement of so many that made these events such a wonderful success. All proceeds will support Glaucoma Research Foundation's sight-saving endeavors. Please save the date for next year's Glaucoma 360: February 6 to 8, 2014.

Last reviewed on October 29, 2017

This article appeared in the May 2013 issue of Gleams.

Subscribe

Was this helpful? Yes No